共 42 条
Inhibition of Mammary Tumor Growth Using Lysyl Oxidase-Targeting Nanoparticles to Modify Extracellular Matrix
被引:95
|作者:
Kanapathipillai, Mathumai
[1
]
Mammoto, Akiko
[2
,3
,4
]
Mammoto, Tadanori
[2
,3
,4
]
Kang, Joo H.
[1
]
Jiang, Elisabeth
[2
,3
,4
]
Ghosh, Kaustabh
[2
,3
,4
]
Korin, Netanel
[1
]
Gibbs, Ashley
[2
,3
,4
]
Mannix, Robert
[2
,3
,4
]
Ingber, Donald E.
[1
,2
,3
,4
,5
]
机构:
[1] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA
关键词:
Cancer;
nanoparticle;
lysyl oxidase;
extracellular matrix;
mechanics;
PLGA NANOPARTICLES;
CANCER;
CLEARANCE;
D O I:
10.1021/nl301206p
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
A cancer nanotherapeutic has been developed that targets the extracellular matrix (ECM)-modifying enzyme lysyl oxidase (LOX) and alters the ECM structure. Poly(D,L-lactide-co-glycolide) nanoparticles (similar to 220 nm) coated with a LOX inhibitory antibody bind to ECM and suppress mammary cancer cell growth and invasion in vitro as well as tumor expansion in vivo, with greater efficiency than soluble anti-LOX antibody. This nanomaterials approach opens a new path for treating cancer with higher efficacy and decreased side effects.
引用
收藏
页码:3213 / 3217
页数:5
相关论文